These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23160109)

  • 1. Early onset of action and sleep-improving effect are crucial in decreasing suicide risk: the role of quetiapine XR in the treatment of unipolar and bipolar depression.
    Pompili M; Rihmer Z; Gonda X; Serafini G; Sher L; Girardi P
    Riv Psichiatr; 2012; 47(6):489-97. PubMed ID: 23160109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antidepressive efficacy of quetiapine XR in unipolar major depression--the role of early onset of action and sleep-improving effect in decreasing suicide risk].
    Rihmer Z
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):211-5. PubMed ID: 20150658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
    Kim SJ; Lee YJ; Lee YJ; Cho SJ
    J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression.
    Todder D; Caliskan S; Baune BT
    J Clin Psychopharmacol; 2006 Dec; 26(6):638-42. PubMed ID: 17110822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
    Findling RL; Pathak S; Earley WR; Liu S; DelBello MP
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice. Bipolar disorder--a focus on depression.
    Frye MA
    N Engl J Med; 2011 Jan; 364(1):51-9. PubMed ID: 21208108
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of quetiapine extended release in the treatment of bipolar depression.
    Cristancho MA; Thase ME
    Adv Ther; 2010 Nov; 27(11):774-84. PubMed ID: 20835785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.
    Endicott J; Rajagopalan K; Minkwitz M; Macfadden W;
    Int Clin Psychopharmacol; 2007 Jan; 22(1):29-37. PubMed ID: 17159457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial.
    Gao K; Wu R; Kemp DE; Chen J; Karberg E; Conroy C; Chan P; Ren M; Serrano MB; Ganocy SJ; Calabrese JR
    J Clin Psychiatry; 2014 Oct; 75(10):1062-8. PubMed ID: 25007003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine monotherapy for bipolar depression.
    Janicak PG; Rado JT
    Expert Opin Pharmacother; 2011 Jul; 12(10):1643-51. PubMed ID: 21609188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on quetiapine for bipolar depression: a 12-month open-label trial.
    Milev R; Abraham G; Zaheer J
    Can J Psychiatry; 2006 Jul; 51(8):523-30. PubMed ID: 16933589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis.
    Catapano-Friedman L
    J Child Adolesc Psychopharmacol; 2001; 11(2):205-6. PubMed ID: 11436963
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder.
    Monti JM
    Sleep Med; 2016 Jul; 23():89-96. PubMed ID: 27692282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on quetiapine in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    CNS Drugs; 2006; 20(5):429-31. PubMed ID: 16696584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.